Inspire Investing LLC Acquires 925 Shares of Acadia Healthcare Company, Inc. $ACHC

Inspire Investing LLC increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 9.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,174 shares of the company’s stock after buying an additional 925 shares during the period. Inspire Investing LLC’s holdings in Acadia Healthcare were worth $339,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. UMB Bank n.a. grew its stake in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock valued at $38,000 after purchasing an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock worth $38,000 after buying an additional 1,234 shares in the last quarter. State of Wyoming bought a new position in Acadia Healthcare in the 4th quarter valued at $56,000. Covestor Ltd raised its position in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company’s stock worth $69,000 after acquiring an additional 812 shares during the last quarter. Finally, Twin Tree Management LP boosted its holdings in Acadia Healthcare by 185.8% in the first quarter. Twin Tree Management LP now owns 5,691 shares of the company’s stock valued at $173,000 after acquiring an additional 3,700 shares during the last quarter.

Acadia Healthcare Trading Up 1.0%

NASDAQ ACHC opened at $21.92 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The stock’s 50-day moving average is $21.95 and its 200-day moving average is $23.97. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $78.66. The firm has a market cap of $2.02 billion, a P/E ratio of 14.52, a P/E/G ratio of 4.27 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on ACHC shares. Guggenheim reduced their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Sunday, August 3rd. Barclays cut their price target on Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 7th. Stephens raised Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Finally, Raymond James Financial reissued an “outperform” rating and issued a $26.00 target price (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $39.00.

View Our Latest Stock Analysis on ACHC

Acadia Healthcare Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Further Reading

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.